Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

A short-term course of dual antiplatelet therapy (DAPT) is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent (DES), researchers reported here.

29 Aug 2016

Anesthetic administered with nasal spray effective in preventing pain during dental treatment

A fear of pain causes many people with dental phobias to avoid or delay needed treatment. In some cases, the injection of a numbing agent can be the most painful part of the visit.

26 Aug 2016

Philips to showcase advanced cardiology solutions at ESC Congress 2016

Royal Philips today announced its presence at the ESC Congress 2016, showcasing its latest in advanced integrated cardiology solutions with a focus on prevention, diagnosis and treatment.

26 Aug 2016

Drinking green tea could prevent abdominal aortic aneurysm

Japan's favorite beverage might be offering more than just a relaxing tea break.

23 Aug 2016

Sutter Health among the first to offer Absorb dissolving stent for patients with coronary artery disease

Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new treatment option, the Abbott Absorb stent, which literally disappears in the body over time.

30 Jul 2016

New study to examine genomics of anti-platelet therapy after coronary interventions

Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty.

29 Jul 2016

PinnacleHealth delivers ABSORB BVS device to first patient after FDA approval

The same PinnacleHealth team that participated in a three-year clinical trial designed to evaluate potential benefits of a first-of-its-kind drug eluting ABSORB Bioresorbable Vascular Scaffold (BVS), today announced it deployed the device for the first time after FDA approval for commercial use.

14 Jul 2016

Leader of materials technology development at Lucideon publishes third book on medical polymers

Lucideon, the materials technology company, is pleased to announce that its Head of Medical Materials, Dr Xiang Zhang, has recently published his third book, Science and Principles of Biodegradable and Bioresorbable Medical Polymers.

From Lucideon 12 Jul 2016

UH cardiologists implant first Abbott Absorb stent on patient with coronary artery disease

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent.

11 Jul 2016

UH implants Abbott's Absorb dissolving stent on coronary artery disease patient

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent works exactly as its traditional metallic predecessors in that it opens a blocked coronary artery, with one major exception - it dissolves completely in the body two to three years after implantation.

10 Jul 2016

Loyola among first health systems to offer absorbable stent to heart patients

Loyola Medicine will be among the first health systems in the country to offer heart patients a new stent that is absorbed by the body once it has served its purpose.

7 Jul 2016

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced that results from the Tryton Confirmatory Study of the company’s Side Branch Stent have been published in JACC Cardiovascular Interventions.

6 Jul 2016

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease.

5 Jul 2016

ADAPT technique offers promising outcomes for stroke patients with large-vessel clots

In an article published online April 16, 2016 by the Journal of Neurointerventional Surgery, investigators at the Medical University of South Carolina report promising 90-day outcomes for stroke patients with large-vessel clots who underwent thrombectomy or clot removal using the direct-aspiration, first pass technique.

30 Jun 2016

Stent retriever devices revolutionize acute ischemic stroke care

New devices called stent retrievers, which effectively reverse strokes, have revolutionized the treatment of certain stroke patients, according to an article in the journal Expert Review of Neurotherapeutics.

25 Jun 2016

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

A first-in-human trial of an everolimus-eluting bioresorbable vascular scaffold has shown that the device can achieve a high 2-year patency rate and low 2-year target lesion revascularisation rate in patients with peripheral artery disease involving the external iliac artery and superficial femoral artery.

23 Jun 2016

Brain imaging finds link between blood-brain barrier disruption and severity of bleeding after stroke therapy

In a study of stroke patients, investigators confirmed through MRI brain scans that there was an association between the extent of disruption to the brain's protective blood-brain barrier and the severity of bleeding following invasive stroke therapy. The results of the National Institutes of Health-funded study were published in Neurology.

20 Jun 2016

Stent News and Research

Further Reading